Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Shoulder Innovations, Inc.NYSE: SI
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 80.4% from a year ago
Cash & equivalents stood at $11.49M at the end of Q1 FY2026, up 80.4% from a year earlier and down 57.2% from the prior quarter.
Context
- Cash & equivalents amounted to 7.2% of total assets at the end of Q1 FY2026, down 3.9 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +80.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 26.87M USD
- Year-over-year change
- +338.9%
- 2-year CAGR
- +107.6%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.87M | +338.9% |
| FY2024 | 2024-12-31 | 6.12M | -1.8% |
| FY2023 | 2023-12-31 | 6.24M | — |
Cash & Equivalents vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 cash & equivalents of $11.49M is the 10th highest of the 11 companies compared; the peer median is $33.02M.
- Its year-over-year change of +80.4% is the 3rd highest of 11, against a peer median of +2.2%.
- Cash & equivalents amounts to 7.2% of total assets for SI, versus a peer median of 21.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $94.41M | -20.6% | -17.8% | 33.0% | |
| Mar 2026 | $62.44M | +135.6% | +44.6% | 63.3% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | $58.69M | +113.8% | +48.2% | 40.2% |
| Dec 2025 | $49.15M | +25.1% | +8.5% | 30.3% | |
| Mar 2026 | $34.93M | -42.0% | -9.8% | 11.1% | |
| Mar 2026 | $31.12M | +32.9% | +3.7% | 13.2% | |
| Mar 2026 | $30.56M | -59.7% | -21.8% | 12.3% | |
| Jun 2026 | $19.21M | -41.5% | +23.3% | 14.5% | |
| Mar 2026 | $14.63M | -56.0% | -52.4% | 8.2% | |
| Mar 2026 | $11.49M | +80.4% | — | 7.2% | |
| Mar 2026 | $10.78M | +26.8% | +118.1% | 29.1% | |
| Peer median (excluding SI) | $33.02M | +2.2% | +6.1% | 21.8% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.